Real-Time Computer Vision Guides Surgeons Through Millimeter-Precision Brain Tumor Removal in World-First Procedure
A London neurosurgery team used AI to color-code critical nerves and blood vessels during a high-stakes pituitary operation where a single millimeter error could cause blindness.

Illustration: AI-generated
Neurosurgeons at University College London Hospitals have successfully completed what they describe as the world's first AI-assisted pituitary tumor removal, using real-time computer vision to navigate one of the brain's most unforgiving surgical landscapes. The procedure, performed in May 2024 and publicly disclosed in August 2026, preserved the vision of 48-year-old Rhys Hibbert from Bedfordshire, who walked out of the hospital without the glasses or mobility aids he had relied on before surgery.
Navigating Sub-Millimeter Margins in the Brain's Danger Zone
The pituitary region presents neurosurgeons with an anatomical minefield where critical structures are packed into millimeter-scale spaces. Hibbert's tumor measured just 11 millimeters (0.4 inches), but its location meant the surgical team at the National Hospital for Neurology and Neurosurgery faced an error tolerance of only 1 millimeter. According to the report, mistakes in this region can result in blindness, stroke, or death.
The AI system, developed by Dr. Sophia Bano, Associate Professor in Robotics and AI at UCL, had previously been used only for research purposes at the hospital. Trained on hundreds of surgical videos, the technology analyzes live video feeds during surgery and applies color-coding to distinguish nerves, blood vessels, and tissue structures in real time—essentially providing surgeons with an augmented view of the surgical field as they work.
From Research Tool to Operating Room Reality
The procedure was conducted as part of a clinical trial funded by the National Institute for Health and Care Research (NIHR). Professor Mike Lewis, scientific director at NIHR, was involved in the trial structure, though the report does not detail specific validation protocols or regulatory pathways used to transition the technology from research to clinical deployment.
Hibbert's outcome was immediate and dramatic: he regained clear vision right after the operation and achieved independent mobility without corrective aids. The case represents a proof-of-concept for intraoperative AI decision support in high-precision neurosurgery, where the consequences of anatomical misidentification are catastrophic.
Implications for Surgical AI Adoption
This milestone raises questions about how surgical AI systems move from laboratory validation to routine clinical use. While the NIHR-funded trial structure provides one model for evidence generation, the healthcare AI community will be watching closely to understand integration requirements, surgeon training protocols, and performance benchmarks that emerge from this and subsequent cases.
For surgical teams working in anatomically complex regions—whether in neurosurgery, vascular surgery, or other precision-dependent specialties—the UCLH case demonstrates that real-time computer vision can function as a practical decision support tool rather than merely a research curiosity. The technology's ability to process live video and provide immediate visual guidance addresses a fundamental challenge in microsurgery: maintaining spatial awareness in crowded anatomical fields where structures may be obscured, compressed, or distorted by pathology.
Sources
Reporting & accountability
How we maintain accuracy
Health AI Central separates reported facts, analysis, and public-source data. Readers can review our standards, request a correction, or consult the relevant research methodology before relying on a claim.